NORTHERN TRUST CORP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,122,610
-16.9%
1,045,381
+3.5%
0.00%0.0%
Q2 2023$9,776,693
-9.5%
1,009,989
+2.5%
0.00%0.0%
Q1 2023$10,803,490
+143.5%
985,720
-4.0%
0.00%
+100.0%
Q4 2022$4,437,147
-41.3%
1,027,117
+2.2%
0.00%
-50.0%
Q3 2022$7,557,000
-26.2%
1,004,868
-1.4%
0.00%0.0%
Q2 2022$10,244,000
+709.8%
1,019,317
+897.3%
0.00%
Q1 2022$1,265,000
-45.5%
102,204
+0.7%
0.00%
Q4 2021$2,321,000
+8.3%
101,476
+4.8%
0.00%
Q3 2021$2,144,00096,8670.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders